Treats schizophrenia. ANDA 83329, held by Hikma. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 83329 (Chlorpromazine Hydrochloride), held by Hikma, was first approved by FDA on Jul 25, 1974, with 19 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the followi…
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 25, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride25MG/ML · injectable;injection | Chlorpromazine Hydrochloride | RxReference drug |
| Feb 5, 2020 | Supplement 47Labeling · Standard review | Approved | None posted |
| Feb 4, 2020 | Supplement 46Labeling · Standard review | Approved | None posted |
| Dec 3, 2010 | Supplement 43Labeling | Approved | None posted |
| Jun 29, 2009 | Supplement 42Labeling | Approved | None posted |
| Nov 25, 2008 | Supplement 41Labeling | Approved | None posted |
| Nov 25, 2002 | Supplement 35Labeling | Approved | None posted |
| Sep 18, 2000 | Supplement 34Manufacturing | Approved | None posted |
| Oct 6, 1999 | Supplement 32Manufacturing | Approved | None posted |
| Oct 6, 1999 | Supplement 33Manufacturing | Approved | None posted |
| Sep 7, 1999 | Supplement 30Manufacturing | Approved | None posted |
| Sep 7, 1999 | Supplement 31Manufacturing | Approved | None posted |
| Apr 14, 1999 | Supplement 29Labeling | Approved | None posted |
| Mar 19, 1998 | Supplement 28Manufacturing | Approved | None posted |
| Dec 9, 1993 | Supplement 27Manufacturing | Approved | None posted |
| Feb 27, 1992 | Supplement 25Manufacturing | Approved | None posted |
| Jan 28, 1991 | Supplement 26Labeling | Approved | None posted |
| Nov 8, 1989 | Supplement 24Labeling | Approved | None posted |
| Feb 15, 1989 | Supplement 21Manufacturing | Approved | None posted |
| Feb 15, 1989 | Supplement 22Manufacturing | Approved | None posted |
| Jul 25, 1974 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters